Last 12 months
Inside the activity.
0 purchase rows · 51 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 12 |
| Dec 2025 | 0 | 11 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2020 Filed Jan 6, 2020 22:14 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
Exercise / conversionSTOCK OPTION (RTB) · Derivative | 620 | $0.00 Strike: $19.60 | $0.00 |
DisclosureSEC source: 0001246360-20-000117 · form.xml · derivative · entry 7 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 620 shares Expires 2028-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option fully vested on February 19, 2019. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:14 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
Exercise / conversionSTOCK OPTION (RTB) · Derivative | 16,666 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001246360-20-000117 · form.xml · derivative · entry 6 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 16,666 shares Expires 2023-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became fully vested on November 4, 2017. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:14 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
Exercise / conversionCOMMON STOCK | 6,250 | $5.04 | $31,500.00 |
DisclosureSEC source: 0001246360-20-000117 · form.xml · nonDerivative · entry 5 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:14 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
Exercise / conversionCOMMON STOCK | 620 | $19.60 | $12,152.00 |
DisclosureSEC source: 0001246360-20-000117 · form.xml · nonDerivative · entry 4 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:14 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
Exercise / conversionCOMMON STOCK | 16,666 | $1.44 | $23,999.04 |
DisclosureSEC source: 0001246360-20-000117 · form.xml · nonDerivative · entry 3 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:14 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
Exercise / conversionCOMMON STOCK | 18,333 | $1.20 | $21,999.60 |
DisclosureSEC source: 0001246360-20-000117 · form.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2019 Filed Dec 11, 2019 00:49 UTC |
BRODERSEN ERICPresident and COO
|
SaleCOMMON STOCK | 2,600 | $30.95 | $80,458.04 |
DisclosureSEC source: 0001246360-19-002658 · form.xml · nonDerivative · entry 2 BRODERSEN ERIC · CIK 0001677723 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported by Mr. Brodersen were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2018. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.65 to $31.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 00:49 UTC |
BRODERSEN ERICPresident and COO
|
SaleCOMMON STOCK | 3,000 | $30.64 | $91,922.10 |
DisclosureSEC source: 0001246360-19-002658 · form.xml · nonDerivative · entry 1 BRODERSEN ERIC · CIK 0001677723 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 F1 · kind: The sales reported by Mr. Brodersen were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2018. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.44 to $30.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 15, 2019 Filed Nov 20, 2019 00:25 UTC |
BYBEE CLINTONDirector
|
OtherCommon Stock | 757 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-19-000711 · edgar.xml · nonDerivative · entry 2 BYBEE CLINTON · CIK 0001219043 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,714 F2 · kind: Distribution of Common Stock held by ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P. to its partners for no consideration. F5 · kind: Change from indirect to direct ownership of shares previously reported as beneficially owned by the reporting person. F2 · price: Distribution of Common Stock held by ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P. to its partners for no consideration. Read SEC document |
| November 15, 2019 Filed Nov 20, 2019 00:25 UTC |
BYBEE CLINTONDirector
|
OtherCommon Stock | 410,820 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-19-000711 · edgar.xml · nonDerivative · entry 1 BYBEE CLINTON · CIK 0001219043 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 F2 · kind: Distribution of Common Stock held by ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P. to its partners for no consideration. F2 · price: Distribution of Common Stock held by ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P. to its partners for no consideration. F1 · balance_after: ARCH Venture Fund V, L.P., and ARCH V Entrepreneurs Fund, L.P. no longer hold shares of the Company. F3 · ownership.nature: Clinton Bybee, a member of the board of directors, is a managing director of ARCH Venture Partners V, LLC, and may be deemed to beneficially own certain of the shares held of record by ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P. Mr. Bybee disclaims beneficial ownership of all shares held of record by ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P., of which he does not have an actual pecuniary interest. By virtue of their relationship as affiliated entities who have overlapping general partners and managing directors, ARCH Venture Fund V, L.P., ARCH V Entrepreneurs Fund, L.P., ARCH Venture Partners V, L.P., ARCH Venture Partners V, LLC and Mr. Bybee may be deemed to share the voting and investment control of the record shares. F4 · ownership.nature: ARCH Venture Partners V, L.P., as the sole general partner of ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P., may be deemed to beneficially own certain of the shares held of record by ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P., but disclaims beneficial ownership of such shares, in which it does not have an actual pecuniary interest. ARCH Venture Partners V, LLC, as the sole general partner of ARCH Venture Partners V, L.P., may be deemed to beneficially own certain of the shares held of record by ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P., but disclaims beneficial ownership of such shares, in which it does not have an actual pecuniary interest. Read SEC document |
| November 15, 2019 Filed Nov 25, 2019 23:56 UTC |
ALBERG TOM ADirector
|
OtherCOMMON STOCK | 2,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-002502 · form.xml · nonDerivative · entry 2 ALBERG TOM A · CIK 0001184752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,107 F2 · kind: Distribution of Common Stock held by ARCH Venture Fund V, L.P. to its partners for no consideration. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 21:56 UTC |
DOSSETT JEFFREYEVP, Sales & Marketing
|
Exercise / conversionSTOCK OPTION (RTB) · Derivative | 250 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001246360-19-002437 · form.xml · derivative · entry 3 DOSSETT JEFFREY · CIK 0001578147 · EVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,971 Underlying: COMMON STOCK · 250 shares Expires 2028-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-fourth of the shares subject to the option vested on November 16, 2018, and 1/48th of the shares subject to the option shall vest on the 3rd day of each month thereafter. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 21:56 UTC |
DOSSETT JEFFREYEVP, Sales & Marketing
|
SaleCOMMON STOCK | 250 | $36.25 | $9,062.50 |
DisclosureSEC source: 0001246360-19-002437 · form.xml · nonDerivative · entry 2 DOSSETT JEFFREY · CIK 0001578147 · EVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 F1 · kind: The sales reported by Mr. Dossett were effected pursuant to a Rule 10b5-1 trading plan adopted on September 6, 2019. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 21:56 UTC |
DOSSETT JEFFREYEVP, Sales & Marketing
|
Exercise / conversionCOMMON STOCK | 250 | $17.33 | $4,332.50 |
DisclosureSEC source: 0001246360-19-002437 · form.xml · nonDerivative · entry 1 DOSSETT JEFFREY · CIK 0001578147 · EVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 23:21 UTC |
ALBERG TOM ADirector
|
SaleCOMMON STOCK | 12,500 | $36.00 | $450,000.00 |
DisclosureSEC source: 0001246360-19-002428 · form.xml · nonDerivative · entry 2 ALBERG TOM A · CIK 0001184752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,769 F2 · kind: The sales reported by Mr. Alberg were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 23:14 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCOMMON STOCK | 9,500 | $35.01 | $332,576.00 |
DisclosureSEC source: 0001246360-19-002427 · form.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,478 F1 · kind: The sales reported by Mr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2019. F2 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 22:14 UTC |
BRODERSEN ERICPresident and COO
|
SaleCOMMON STOCK | 3,000 | $34.51 | $103,544.70 |
DisclosureSEC source: 0001246360-19-002393 · form.xml · nonDerivative · entry 4 BRODERSEN ERIC · CIK 0001677723 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,600 F1 · kind: The sales reported by Mr. Brodersen were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2018. F5 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $34.01 to $34.865, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 21:42 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
GiftCOMMON STOCK | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-002397 · form.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,978 Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 21:35 UTC |
ALBERG TOM ADirector
|
SaleCOMMON STOCK | 6,000 | $35.00 | $210,000.00 |
DisclosureSEC source: 0001246360-19-002396 · form.xml · nonDerivative · entry 3 ALBERG TOM A · CIK 0001184752 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Raven Trust Fund Disclosed balance after: 19,219 F1 · kind: The sales reported by Mr. Alberg were effected pursuant to a Rule 10b5-1 trading plan. F2 · ownership.nature: Shares held of record by Raven Trust Fund. Mr. Alberg shares voting and dispositive control over such shares but disclaims beneficial ownership over such shares. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 21:35 UTC |
ALBERG TOM ADirector
|
SaleCOMMON STOCK | 6,000 | $33.89 | $203,340.00 |
DisclosureSEC source: 0001246360-19-002396 · form.xml · nonDerivative · entry 2 ALBERG TOM A · CIK 0001184752 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Raven Trust Fund Disclosed balance after: 25,219 F1 · kind: The sales reported by Mr. Alberg were effected pursuant to a Rule 10b5-1 trading plan. F2 · ownership.nature: Shares held of record by Raven Trust Fund. Mr. Alberg shares voting and dispositive control over such shares but disclaims beneficial ownership over such shares. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 22:14 UTC |
BRODERSEN ERICPresident and COO
|
SaleCOMMON STOCK | 800 | $35.19 | $28,149.76 |
DisclosureSEC source: 0001246360-19-002393 · form.xml · nonDerivative · entry 3 BRODERSEN ERIC · CIK 0001677723 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,600 F1 · kind: The sales reported by Mr. Brodersen were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2018. F4 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 22:14 UTC |
BRODERSEN ERICPresident and COO
|
SaleCOMMON STOCK | 1,900 | $34.58 | $65,708.46 |
DisclosureSEC source: 0001246360-19-002393 · form.xml · nonDerivative · entry 2 BRODERSEN ERIC · CIK 0001677723 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,400 F1 · kind: The sales reported by Mr. Brodersen were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2018. F3 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $33.99 to $34.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 22:14 UTC |
BRODERSEN ERICPresident and COO
|
SaleCOMMON STOCK | 800 | $33.27 | $26,617.52 |
DisclosureSEC source: 0001246360-19-002393 · form.xml · nonDerivative · entry 1 BRODERSEN ERIC · CIK 0001677723 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,300 F1 · kind: The sales reported by Mr. Brodersen were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2018. F2 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $32.91 to $33.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 23, 2019 Filed Oct 24, 2019 23:08 UTC |
ALBERG TOM ADirector
|
GrantRestricted Stock Units · Derivative | 3,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-002278 · form.xml · derivative · entry 1 ALBERG TOM A · CIK 0001184752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,411 Underlying: COMMON STOCK · 3,411 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F2 · derivative.exercise_date: The restricted stock units will fully vest on October 23, 2020. F2 · derivative.expiration_date: The restricted stock units will fully vest on October 23, 2020. Read SEC document |
| October 23, 2019 Filed Oct 24, 2019 23:08 UTC |
WISE THERESADirector
|
GrantRestricted Stock Units · Derivative | 3,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-002279 · form.xml · derivative · entry 1 WISE THERESA · CIK 0001677728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,411 Underlying: COMMON STOCK · 3,411 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F2 · derivative.exercise_date: The restricted stock units will fully vest on October 23, 2020. F2 · derivative.expiration_date: The restricted stock units will fully vest on October 23, 2020. Read SEC document |
| October 23, 2019 Filed Oct 24, 2019 19:07 UTC |
VAN OPPEN PETER HDirector
|
GrantRestricted Stock Units · Derivative | 4,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-002277 · form.xml · derivative · entry 1 VAN OPPEN PETER H · CIK 0001057881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,264 Underlying: COMMON STOCK · 4,264 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F2 · derivative.exercise_date: The restricted stock units will fully vest on October 23, 2020. F2 · derivative.expiration_date: The restricted stock units will fully vest on October 23, 2020. Read SEC document |
| October 23, 2019 Filed Oct 24, 2019 23:10 UTC |
PHELAN CATHAL GDirector
|
GrantRestricted Stock Units · Derivative | 3,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-002283 · form.xml · derivative · entry 1 PHELAN CATHAL G · CIK 0001259761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,411 Underlying: COMMON STOCK · 3,411 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F2 · derivative.exercise_date: The restricted stock units will fully vest on October 23, 2020. F2 · derivative.expiration_date: The restricted stock units will fully vest on October 23, 2020. Read SEC document |
| October 23, 2019 Filed Oct 24, 2019 23:08 UTC |
SESSLER GREGORYDirector
|
GrantRestricted Stock Units · Derivative | 3,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-002281 · form.xml · derivative · entry 1 SESSLER GREGORY · CIK 0001285810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,411 Underlying: COMMON STOCK · 3,411 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F2 · derivative.exercise_date: The restricted stock units will fully vest on October 23, 2020. F2 · derivative.expiration_date: The restricted stock units will fully vest on October 23, 2020. Read SEC document |
| October 23, 2019 Filed Oct 24, 2019 23:09 UTC |
Gibson Daniel PatrickDirector · 10% owner
|
GrantRestricted Stock Units · Derivative | 3,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-002282 · form.xml · derivative · entry 1 Gibson Daniel Patrick · CIK 0001745725 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,411 Underlying: COMMON STOCK · 3,411 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F2 · derivative.exercise_date: The restricted stock units will fully vest on October 23, 2020. F2 · derivative.expiration_date: The restricted stock units will fully vest on October 23, 2020. Read SEC document |
| October 23, 2019 Filed Oct 24, 2019 23:08 UTC |
BYBEE CLINTONDirector
|
GrantRestricted Stock Units · Derivative | 3,411 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-002280 · form.xml · derivative · entry 1 BYBEE CLINTON · CIK 0001219043 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,411 Underlying: COMMON STOCK · 3,411 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F2 · derivative.exercise_date: The restricted stock units will fully vest on October 23, 2020. F2 · derivative.expiration_date: The restricted stock units will fully vest on October 23, 2020. Read SEC document |
| October 10, 2019 Filed Oct 11, 2019 20:14 UTC |
BRODERSEN ERICPresident and COO
|
SaleCOMMON STOCK | 3,500 | $31.62 | $110,686.45 |
DisclosureSEC source: 0001246360-19-002228 · form.xml · nonDerivative · entry 2 BRODERSEN ERIC · CIK 0001677723 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,100 F1 · kind: The sales reported by Mr. Brodersen were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2018. F3 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $31.41 to $31.78, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 09, 2019 Filed Oct 11, 2019 20:14 UTC |
BRODERSEN ERICPresident and COO
|
SaleCOMMON STOCK | 3,500 | $31.00 | $108,484.25 |
DisclosureSEC source: 0001246360-19-002228 · form.xml · nonDerivative · entry 1 BRODERSEN ERIC · CIK 0001677723 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,600 F1 · kind: The sales reported by Mr. Brodersen were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2018. F2 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.70 to $31.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 17, 2019 Filed Sep 17, 2019 23:49 UTC |
BRODERSEN ERICPresident and COO
|
SaleCOMMON STOCK | 1,100 | $34.89 | $38,374.49 |
DisclosureSEC source: 0001246360-19-002109 · form.xml · nonDerivative · entry 3 BRODERSEN ERIC · CIK 0001677723 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,100 F1 · kind: The sales reported by Mr. Brodersen were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2018. F4 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $34.76 to $34.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 17, 2019 Filed Sep 17, 2019 23:49 UTC |
BRODERSEN ERICPresident and COO
|
SaleCOMMON STOCK | 2,400 | $34.48 | $82,760.40 |
DisclosureSEC source: 0001246360-19-002109 · form.xml · nonDerivative · entry 2 BRODERSEN ERIC · CIK 0001677723 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,200 F1 · kind: The sales reported by Mr. Brodersen were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2018. F3 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $33.75 to $34.72, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 17, 2019 Filed Sep 18, 2019 22:42 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCOMMON STOCK | 10,000 | $35.00 | $350,000.00 |
DisclosureSEC source: 0001246360-19-002113 · form.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,978 F1 · kind: The sales reported by Mr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2019. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 23:49 UTC |
BRODERSEN ERICPresident and COO
|
SaleCOMMON STOCK | 3,500 | $33.57 | $117,510.75 |
DisclosureSEC source: 0001246360-19-002109 · form.xml · nonDerivative · entry 1 BRODERSEN ERIC · CIK 0001677723 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,600 F1 · kind: The sales reported by Mr. Brodersen were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2018. F2 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $33.20 to $33.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 10, 2019 Filed Sep 11, 2019 20:42 UTC |
SESSLER GREGORYDirector
|
SaleCOMMON STOCK | 5,828 | $32.20 | $187,666.85 |
DisclosureSEC source: 0001246360-19-002093 · form.xml · nonDerivative · entry 1 SESSLER GREGORY · CIK 0001285810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,864 F1 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $32.1632 to $32.2232, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 09, 2019 Filed Sep 9, 2019 21:56 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCOMMON STOCK | 500 | $35.22 | $17,612.00 |
DisclosureSEC source: 0001246360-19-002085 · form.xml · nonDerivative · entry 4 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,978 F1 · kind: The sales reported by Mr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2019. F4 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $35.19 to $35.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 06, 2019 Filed Sep 9, 2019 21:56 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCOMMON STOCK | 1,500 | $36.32 | $54,484.95 |
DisclosureSEC source: 0001246360-19-002085 · form.xml · nonDerivative · entry 3 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,478 F1 · kind: The sales reported by Mr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2019. F3 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $36.05 to $36.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 06, 2019 Filed Sep 9, 2019 21:56 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCOMMON STOCK | 8,500 | $35.36 | $300,520.90 |
DisclosureSEC source: 0001246360-19-002085 · form.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,978 F1 · kind: The sales reported by Mr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2019. F2 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 06, 2019 Filed Oct 4, 2019 23:28 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
GrantSTOCK OPTION (RTB) · Derivative | 62,500 | $0.00 Strike: $35.16 | $0.00 |
DisclosureSEC source: 0001246360-19-002198 · form.xml · derivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: COMMON STOCK · 62,500 shares Expires 2019-09-05 F2 · derivative.exercise_date: One-fourth of the shares subject to the option shall vest on July 1, 2020, and 1/48th of the shares subject to the option shall vest each month thereafter. Read SEC document |
| September 05, 2019 Filed Oct 4, 2019 23:28 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 62,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-002198 · form.xml · derivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: COMMON STOCK · 62,500 shares Expires 2019-09-04 F1 · derivative.exercise_date: One-fourth of the shares subject to the grant shall vest on July 1, 2020, and 1/16th of the shares subject to the grant shall vest each quarter thereafter. Read SEC document |
| August 28, 2019 Filed Aug 30, 2019 22:33 UTC |
BYBEE CLINTONDirector
|
OtherCommon Stock | 610 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-19-000594 · edgar.xml · nonDerivative · entry 2 BYBEE CLINTON · CIK 0001219043 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,957 F2 · kind: Distribution of Common Stock held by ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P. to its partners for no consideration. F5 · kind: Change from indirect to direct ownership of shares previously reported as beneficially owned by the reporting person. F2 · price: Distribution of Common Stock held by ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P. to its partners for no consideration. Read SEC document |
| August 28, 2019 Filed Aug 30, 2019 22:33 UTC |
BYBEE CLINTONDirector
|
OtherCommon Stock | 331,781 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-19-000594 · edgar.xml · nonDerivative · entry 1 BYBEE CLINTON · CIK 0001219043 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 410,820 F2 · kind: Distribution of Common Stock held by ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P. to its partners for no consideration. F2 · price: Distribution of Common Stock held by ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P. to its partners for no consideration. F1 · balance_after: 408,183 of these shares are held of record by ARCH Venture Fund V, L.P., and 2,637 of these shares are held of record by ARCH V Entrepreneurs Fund, L.P. F3 · ownership.nature: Clinton Bybee, a member of the board of directors, is a managing director of ARCH Venture Partners V, LLC, and may be deemed to beneficially own certain of the shares held of record by ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P. Mr. Bybee disclaims beneficial ownership of all shares held of record by ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P., of which he does not have an actual pecuniary interest. By virtue of their relationship as affiliated entities who have overlapping general partners and managing directors, ARCH Venture Fund V, L.P., ARCH V Entrepreneurs Fund, L.P., ARCH Venture Partners V, L.P., ARCH Venture Partners V, LLC and Mr. Bybee may be deemed to share the voting and investment control of the record shares. F4 · ownership.nature: ARCH Venture Partners V, L.P., as the sole general partner of ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P., may be deemed to beneficially own certain of the shares held of record by ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P., but disclaims beneficial ownership of such shares, in which it does not have an actual pecuniary interest. ARCH Venture Partners V, LLC, as the sole general partner of ARCH Venture Partners V, L.P., may be deemed to beneficially own certain of the shares held of record by ARCH Venture Fund V, L.P. and ARCH V Entrepreneurs Fund, L.P., but disclaims beneficial ownership of such shares, in which it does not have an actual pecuniary interest. Read SEC document |
| August 28, 2019 Filed Aug 30, 2019 21:07 UTC |
ALBERG TOM ADirector
|
OtherCOMMON STOCK | 1,887 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-002037 · form.xml · nonDerivative · entry 2 ALBERG TOM A · CIK 0001184752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,269 F2 · kind: Distribution of Common Stock held by ARCH Venture Fund V, L.P. to its partners for no consideration. F2 · shares: Distribution of Common Stock held by ARCH Venture Fund V, L.P. to its partners for no consideration. Read SEC document |
| August 20, 2019 Filed Feb 11, 2020 22:56 UTC |
MASTERS DENISEVP Accounting
|
GrantCOMMON STOCK | 472 | $16.50 | $7,788.00 |
DisclosureSEC source: 0001246360-20-000450 · form.xml · nonDerivative · entry 2 MASTERS DENISE · CIK 0001736540 · VP Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,732 F3 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP Purchase Period (as defined in the ESPP) of February 20, 2019 through August 20, 2019. This transaction is also exempt under Rule 16b-3(c). F4 · shares: The Purchase Period ended August 20, 2019 and is the first of two Purchase Periods comprising the Offering Period (as defined in the ESPP) that began February 20, 2019. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 16:49 UTC |
VAN OPPEN PETER HDirector
|
Exercise / conversionRESTRICTED STOCK UNITS - 2018 · Derivative | 5,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-001981 · form.xml · derivative · entry 4 VAN OPPEN PETER H · CIK 0001057881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 5,942 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On August 13, 2018, the reporting person was granted 5,942 restricted stock units (RSUs). These RSUs fully vested on August 13, 2019. F5 · derivative.expiration_date: On August 13, 2018, the reporting person was granted 5,942 restricted stock units (RSUs). These RSUs fully vested on August 13, 2019. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 16:49 UTC |
VAN OPPEN PETER HDirector
|
SaleCOMMON STOCK | 4,372 | $36.83 | $161,009.39 |
DisclosureSEC source: 0001246360-19-001981 · form.xml · nonDerivative · entry 3 VAN OPPEN PETER H · CIK 0001057881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F3 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $36.68 to $37.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 16:49 UTC |
VAN OPPEN PETER HDirector
|
SaleCOMMON STOCK | 4,098 | $35.89 | $147,060.42 |
DisclosureSEC source: 0001246360-19-001981 · form.xml · nonDerivative · entry 2 VAN OPPEN PETER H · CIK 0001057881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,372 F2 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $35.55 to $36.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 16:49 UTC |
VAN OPPEN PETER HDirector
|
Exercise / conversionCOMMON STOCK | 5,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-001981 · form.xml · nonDerivative · entry 1 VAN OPPEN PETER H · CIK 0001057881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert to common stock on a one to one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.